Advanced search
Publication Cover
Biomarkers Volume 23, 2018 - Issue 2
Submit an article Journal homepage
240
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel–Lindau patients

Giorgia MandiliDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin Medical School, Turin, Italy; ;Center for Experimental Research and Medical Studies (CeRMS), Città della Salute e della Scienza, Ospedale San Giovanni Battista, Turin, Italy; Correspondence[email protected]
View further author information
,
Agata NotarpietroDepartment of Oncology, University of Turin Medical School, Turin, Italy; View further author information
,
Amina KhadjaviDepartment of Surgical Sciences, University of Turin Medical School, Turin, Italy; View further author information
,
Marco AllasiaDepartment of Urology, Azienda Ospedaliera Città della Salute e Della Scienza di Torino – Molinette, Turin, Italy; View further author information
,
Antonino BattagliaDepartment of Urology, Azienda Ospedaliera Città della Salute e Della Scienza di Torino – Molinette, Turin, Italy; View further author information
,
Barbara LucatelloDepartment of Endocrinology, Diabetology and Metabolism, Azienda Ospedaliera Città della Salute e Della Scienza di Torino – Molinette, Turin, Italy; View further author information
,
Bruno FreaDepartment of Urology, Azienda Ospedaliera Città della Salute e Della Scienza di Torino – Molinette, Turin, Italy; View further author information
,
Francesco TurriniDepartment of Oncology, University of Turin Medical School, Turin, Italy; View further author information
,
Francesco NovelliDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin Medical School, Turin, Italy; ;Center for Experimental Research and Medical Studies (CeRMS), Città della Salute e della Scienza, Ospedale San Giovanni Battista, Turin, Italy; ;Immunogenetics and Transplantation Biology Unit, Azienda Ospedaliera Città della Salute e della Scienza, Ospedale San Giovanni Battista, Turin, ItalyORCID Iconhttp://orcid.org/0000-0002-6259-5666View further author information
ORCID Icon,
Giuliana GiribaldiDepartment of Oncology, University of Turin Medical School, Turin, Italy; View further author information
&
Paolo DestefanisDepartment of Urology, Azienda Ospedaliera Città della Salute e Della Scienza di Torino – Molinette, Turin, Italy; View further author information
 show all
Pages 123-130 | Received 13 Jun 2016, Accepted 26 Nov 2016, Published online: 22 Dec 2016

References

  • Bader, H.L. and Hsu, T., 2012. Systemic VHL gene functions and the VHL disease. FEBS letters, 586, 1562–1569.
  • Barontini, M. and Dahia, P.L., 2010. VHL disease. Best practice & research clinical endocrinology & metabolism, 24, 401–413.
  • Barrisford, G.W., et al., 2011. Familial renal cancer: molecular genetics and surgical management. International journal of surgical oncology, 2011, 658767–658778.
  • Bodmer, D., et al., 2002. Understanding familial and non-familial renal cell cancer. Human molecular genetics, 11, 2489–2498.
  • Boichenko, A.P., et al., 2014. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. The journal of proteome research, 13, 4995–5007.
  • Chung, L., et al., 2014. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer research, 16, R63–R75.
  • Gebregiworgis, T., et al., 2016. A urinary metabolic signature for multiple sclerosis and neuromyelitis optica. Journal of proteome research, 15, 659–666.
  • Gilcrease, M.Z., et al., 1995. Somatic von Hippel–Lindau mutation in clear cell papillary cystadenoma of the epididymis. Human pathology, 26, 1341–1346.
  • Giribaldi, G., et al., 2013. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. Journal of proteomics, 91, 385–392.
  • Hsu, T., 2012. Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms. Oncogene, 31, 2247–2257.
  • Jing, X., et al., 2010. Beta2-GPI: a novel factor in the development of hepatocellular carcinoma. Journal of cancer research and clinical oncology, 136, 1671–1680.
  • Lee, S.W., et al., 2012. Use of MDLC-DIGE and LC-MS/MS to identify serum biomarkers for complete remission in patients with acute myeloid leukemia. Electrophoresis, 33, 1863–1872.
  • Liang, Y., et al., 2015. Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology, 25, 331–340.
  • Lisowska-Myjak, B., 2005. AAT as a diagnostic tool. Clinica chimica acta, 352, 1–13.
  • Lonser, R.R., et al., 2003. von Hippel-Lindau disease. Lancet, 361, 2059–2067.
  • López, J.I., 2013. Renal tumors with clear cells. A review. Pathology, research and practice, 209, 137–146.
  • Maher, E.R., Neumann, H.P., and Richard, S., 2011. von Hippel-Lindau disease: a clinical and scientific review. The European journal of human genetics, 19, 617–623.
  • Mandili, G., et al., 2011. Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells. PLoS one, 6, e18254–e1865.
  • Miyake, M., et al., 2013. Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection. BMC urology, 13, 42–52.
  • Norden, A.G., et al., 1991. Excretion of beta 2-glycoprotein I (apolipoprotein H) in renal tubular disease. Clinical chemistry, 37, 74–77.
  • Passam, F.H., et al., 2010. In vivo modulation of angiogenesis by beta 2 glycoprotein I. Journal of autoimmunity, 35, 232–240.
  • Pérez-Holanda, S., et al., 2014. Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC cancer, 14, 355–364.
  • Pietrowska, M., et al., 2014. Identification of serum proteome components associated with progression of non-small cell lung cancer. ACTA biochimica polonica, 61, 325–331.
  • Richard, S., et al., 2013. Von Hippel-Lindau: how a rare disease illuminates cancer biology. Seminars in cancer biology, 23, 26–37.
  • Zager, R.A., Johnson, A.C., and Frostad, K.B., 2014. Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injury. PLoS one, 9, e98380.93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.